LIN:NASDAQLinde plc Analysis
Data as of 2026-09-05 - not real-time
$477.57
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
At $477.57, Linde plc shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 6.8%. RSI sits at 38.5, which reads as approaching oversold, and MACD momentum is bullish. Recent trading has carved out support near $473.05 and resistance around $495.96.
The shares look fair at 30.9 times earnings, though no sector average was available for comparison. Sell-side targets cluster 14.0% above the current quote. Revenue is growing at 9.3% on a 20.4% profit margin. The 1.33% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 22.5%, a beta of 0.08 and a maximum drawdown of 19.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
The shares look fair at 30.9 times earnings, though no sector average was available for comparison. Sell-side targets cluster 14.0% above the current quote. Revenue is growing at 9.3% on a 20.4% profit margin. The 1.33% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 22.5%, a beta of 0.08 and a maximum drawdown of 19.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Top Market Events
Linde stock stayed close to $490 after a $4.Linde PLC LIN reports near double-digit growth in Q2 2026, driven by electronics and manufacturing recovery, while...Linde stock is trading close to recent highs after Q2 2026 results showed a profit margin above 20 p
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 480.48
- MACD momentum is positive
- 30-day price change of -6.8%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 480.48
- Analyst targets imply +14.0% versus the current price
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Analyst targets imply +14.0% versus the current price
- Profit margin of 20.4% is healthy
- P/E ratio of 30.9
Key Metrics & Analysis
Financial Health
Revenue Growth9.30%
Profit Margin20.43%
P/E Ratio30.9
ROE18.40%
ROA7.16%
Debt/Equity68.95
P/B Ratio5.6
Op. Cash Flow$10.5B
Free Cash Flow$4.2B
Technical Analysis
TrendNeutral
RSI38.5
Support$473.05
Resistance$495.96
MA 20$484.62
MA 50$501.51
MA 200$480.48
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
Fair Value$118.96
Target Price$544.54
Upside/Downside14.02%
GradeFair
TypeGrowth
Dividend Yield1.33%
Risk Assessment
Beta0.08
Volatility22.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.